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Abstract
OBJECTIVE: To test the reliability and validity of
dermatology life quality index (DLQI) in simplified
Chinese language by assessing the quality of life
(QoL) in HIV (human immunodeficiency virus)/AIDS
(Acquired immunodeficiency syndrome) patients
with pruritic papular eruption (PPE).
METHODS: A study of simplified-Chinese-version
DLQI was carried out in Henan province, China. The
reliability and validity were tested by means of sta-
tistical method. Data were processed with SPSS
19.0.
RESULTS: One hundred and seven subjects partici-
pated in the study and 106 (99.07% ) finished the
questionnaire. Eighteen patients were mildly affect-
ed; 62 were moderately affected, 24 were highly af-
fected, and 2 were extremely affected. Reliability
analysis showed that the split-half reliability coeffi-
cient of questionnaire was 0.556 and the reliability
of the full test estimated with Spearman-Brown.
correction was 0.7146. The Cronbach alpha was
0.673. According to validity analysis, the correlation
between the scores of items and the total scores
ranged from 0.208 to 0.529 (P<0.05). Three factors
were abstracted from10 questions with the princi-
pal component analysis and the contribution rate
of the 3 common factors was 59.95%.
CONCLUSION: The simplified-Chinese-version
DIQL is an acceptable and valid scale for HIV/AIDS
patients with PPE. It can be used to evaluate the
QoL of HIV/AIDS patients with PPE in China.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Acquired immunodeficiency syndrome (AIDS), caused
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by the human immunodeficiency virus (HIV), has be-
come a major public health issue in China. Since
1985, the first Chinese HIV/AIDS case was reported
in Peking Union Medical College Hospital.1 It was esti-
mated that by the end of 2011, there were approximately
780 000 HIV-1 positive patients in China, including
about 154 000 AIDS patients and about 48 000 new
HIV-infected patients in 2011.2
Fortunately, along with the development of com-
bined antiretroviral therapy (cART) and prevention,
the mortality and morbidity of HIV/AIDS were de-
clined remarkably, and it is well known that HIV/
AIDS has become a chronic and potentially manage-
able disease.3
At present, more attention was paid not only to the an-
tiviral treatment, e.g. the recovery of immune func-
tion, reducing of infection complications, decrease of
viral loads, side-effects and resistance of cART, but also
to the quality of life (QoL) of AIDS patients. QoL as a
multidimensional concept with cultural, social, psycho-
logical and health dimensions, is believed to be a good
measure of health status.4
In 1994, the dermatology life quality index (DLQI)5
was developed by Finlay and Khan, which was de-
signed to measure the impact of skin conditions on
QoL. It has been a widely used questionnaire for life
quality assessment and translated into 85 languages in-
cluding simplified Chinese version and used in over 33
skin conditions.
DLQI has been used in China for years in various con-
ditions except pruritic papular eruption (PPE). Howev-
er no studies were reported on the assessment of PPE
with DLQI. In this article, we reported our study on
the reliability and validity of DLQI by assessing the
condition.
METHODS
Subjects
This study, a part work of the project funded by Na-
tional Special S & T Program on Major Infectious Dis-
eases, was carried out from May to June 2010 in Shang-
cai county of Henan province. Inclusion criteria: the
subjects aged over 18 years and voluntarily participated
in the study and signed the informed consent form;
they had been diagnosed with HIV/AIDS according to
the guidelines for diagnosis and treatment of HIV/
AIDS in China (2005)6 and the PPE according to the
itching, sporadic, papule or nodules as the main type
of skin rash for more than 1-month duration by two
clinical doctors; the PPE had not been treated in the
last two weeks.
Exclusion criteria: patients with psychiatric diseases in-
cluding serious hysteria; pregnant or lactating patients;
subjects prepared to be pregnant; any diseases which
could affect test results according to the researchers'
judgment.
Demographics
Demographics included age, gender, marital status, ed-
ucation, occupation, cART time and obstetrical history.
DLQI
It is a questionnaire with 10 questions involving in
symptoms and feelings, daily activities, leisure, work
and school, personal relationships and treatment. The
scores ranged from 0 to 30. The higher the score, the
worse the QoL. The scores of 0 to 1 indicated no effect
at all on patient's life, 2 to 5 mild effect, 6 to 10 mod-
erate effect, 11 to 20 high effect and 21 to 30 extreme-
ly high effect.
Survey method
Interviewers had been trained strictly before conduct-
ing the survey. A unified cases report form was used to
be filled out on the scene by the interviewers or by the
subjects.
Statistical analyses
Data were analyzed with SPSS 19.0 software package
(SPSS Inc., Chicago, IL, USA). Spearman correlation
coefficients were calculated for item scores and total
scores. We used reliability analysis with Cronbach al-
pha for internal consistency evaluation and factor anal-
ysis for structure validity evaluation. Statistical signifi-
cance was accepted as P<0.05.
Ethical consideration
Ethical approval was obtained from the Institutional
Review Board of the First Affiliated Hospital of Henan
University of TCM. Written informed consent was ob-
tained from each subject before recruited in the study.
RESULTS
Demographics
One hundred and seven subjects participated in the
survey and 106 (99.07% ) patients finished the ques-
tionnaire. Among them, 38 (35.85% ) males and 68
(64.15% ) females aged from 32 to 64 years old, and
the average age was 48 ± 8. Forty (37.74% ) patients
were illiterate and 23 (21.70% ) patients graduated
from middle school. Eighty (75.47%) patients married
and 26 (24.53%) patients were in divorced, widowed
or single status.
DLQI scores
Among 106 patients, the total scores of six domains
were 914, the mean was 8.62. The maximum scores
were 24 and the minimum scores were 3. Eighteen pa-
tients were mildly affected; 62 moderately affected; 24
highly affected; 2 extremely affected.
Reliability
Reliability analysis showed that the split-half reliability
coefficient of questionnaire was 0.556 and the reliabili-
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ty estimated for the full test with Spearman-Brown cor-
rection was 0.7146. The Cronbach alpha was 0.673.
Cronbach alpha reliability coefficients for the six di-
mensions (Symptoms and feelings, Daily activities, Lei-
sure, Work and School, Personal relationships and
Treatment) were 0.633, 0.777, 0.771, 0.785, 0.772
and 0.684 respectively.
Content validity
The correlations between the scores of items and the to-
tal scores ranged from 0.208 to 0.529 (P<0.05). Ex-
ploratory factor analysis was used to check structure va-
lidity, Kaiser-Meyer-Olkin (KMO) value was 0.673
and Bartlett test result was 254.69 (P<0.001). Three
common factors were abstracted from 10 questions by
the principal component analysis. The contribution
rate of the 3 common factors was 59.95%. Among the
3 common factors, factor 1 included Question 4-10,
factor 2 includes Question 1-4, and factor 3 includes
Question 4, 5 and 9.
DISCUSSION
PPE is the most common cutaneous manifestation
among HIV/AIDS patients,7 with a prevalence ranging
from 11% to 46% depending on the geographic area.8
In China, reported researches on PPE among HIV/
AIDS were few. The incidence of PPE is still unknown.
Some researchers regarded PPE as good clinical indica-
tor of advancing immune suppression,9 even as the first
marker of HIV infection with a high positive predic-
tive value.10
At present, more consistent view is that the eruptions
appear not only in the advanced immunosuppressive
stage of the disease but also in the initial cutaneous dis-
ease of the HIV with high CD4 + T lymphocyte
counts.11 PPE has been observed for a few decades, but
the etiology and the exact spectrum of PPE are still un-
clear.12 Although varying therapeutic methods such as
ultraviolet B rays, antihistamines and potent corticoste-
roids have been used in clinical practice, the effect is
still not satisfactory.
At present, QoL indices are recognized as crucial out-
come measures in therapeutic interventions for the lim-
itations of the traditional assessment of medical and
surgical outcomes. It is well known that some skin-dis-
eases impact on patients' lives in terms of psychological
well-being, social functioning and activities,13 and as-
sessment of QoL has become an important endpoint
in clinical trials besides traditional clinical outcomes.14
In order to evaluate QoL, some instruments had been
formulated and used in past decades, e.g. SF-36,15 HO-
QoL-HIV16 and QoL-index.17 Some measurements of
QoL have general applicability, but the others can only
be used on a specific disease.
The disease specific instruments of QoL being the ma-
jority measurement tools have been used to measure
specific areas of health, functioning and QoL relevant
to a particular disease and treatment, such as DLQI for
skin disease, WHOQOL-HIV for HIV/AIDS and
Cancer Related Fatigue Scale for fatigue among cancer
patients.18 Among those instruments, DLQI is widely
used in skin diseases.19
In the past decade, the simplified-Chinese-version
DLQI had been used in China.20 It was proved an effi-
cient instrument with better reliability and validity con-
ducted on 215 patients.21
Although some researchers used the simplified-Chi-
nese-version in some skin diseases including onychomy-
cosis,22 pemphigus and bullous pemphigoid,23 vitiligo24
and alopecia areata,25 no study reported the results of
assessing PPE of HIV/AIDS with DLQI and tested its
reliability and validity.
Reliability analysis showed that the split-half reliability
coefficient of questionnaire was 0.556 and the Spear-
man-Brown correction reliability was 0.7146, and
Cronbach alpha reliability coefficient was 0.673. These
revealed that the questionnaire had an acceptable inter-
nal consistency.
The correlation between the scores of items and the to-
tal scores ranged from 0.208 to 0.529 (P<0.05). The
three common factors were derived from 10 questions
by the principal component analysis with the contribu-
tion rate of 59.95%.This suggested that the question-
naire had acceptable construct validity.
In conclusion, the simplified-Chinese-version DLQI is
a reliable and valid scale. It can be used to evaluate
QoL of HIV/AIDS patients with PPE in China.
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